FEB 23, 2017 1:25 PM PST

"STING" Protein Activates As Immune Cells Recognize Viral DNA

WRITTEN BY: Kara Marker

Scientists keep chipping away at the mysteries of the immune system, and this time in a new study published in Nature Communications, they discovered two new proteins involved in the innate immune response to foreign DNA.

A DNA virus has DNA as its genetic material and replicates using DNA-dependent DNA polymerase. Source: Tech Times

Immune cells might recognize DNA as foreign if it is cancerous or from a virus, and from the moment of recognition, cells burst into action, triggering a domino effect of reactions that begin with the production of interferon, signaling to nearby cells that foreign DNA is in their midst.

From a research team at Aarhus University, experts found a new protein playing vital role in the domino effect: “STING.” This protein acts as an immunological doorknob to initiate interferon and chemical messenger production in response to the detection of foreign DNA floating around outside of the cell.

During their study, researchers investigated the function of STING in immune cells called macrophages which engulf and destroy foreign invaders. One by one, they deleted macrophage genes to see if their absence had any effect on STING function. This is where they identified that the gene coding for another protein, called IFI16, was necessary for macrophages to produce interferon in response to tumor or viral DNA.

“IFI16, which most of our immune cells carry, has crucial significance for the cell's defense against microorganisms or dying cells' release of DNA," explained study researcher Martin Roelsgaard Jakobsen.

Comprehending the role of both IFI16 and STING has implications for cancer immunotherapy, new antiviral strategies, and even autoimmune disease treatment.

"STING's function and its degree of activity play a significant role in how well the body fights conditions when it is exposed to something that is foreign or abnormal such as infections and cancer," Jakobsen explained. "By using different molecular biological methods, we could clearly demonstrate that our immune cells only need a very small fraction of the IFI16 protein for STING to function optimally.”

Jakobsen and his team hope to develop new immunotherapy tactics based on manipulating STING within the next few years. The plan of action, he said, would be to “go directly in and boost the innate immune defense system in the cancerous tumor by using molecules that targets and triggers STING and IFI16 function.”

Source: Aarhus University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
MAY 13, 2021
Immunology
Tumors Hide From the Immune System by Masquerading as Baby Cells
MAY 13, 2021
Tumors Hide From the Immune System by Masquerading as Baby Cells
The immune system is programmed to recognize foreign bodies as potentially dangerous, promptly removing them before the ...
MAY 31, 2021
Immunology
Engineering Faster, More Agile T Cell Cancer Fighters
MAY 31, 2021
Engineering Faster, More Agile T Cell Cancer Fighters
Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
JUN 08, 2021
Immunology
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
JUN 08, 2021
Is the Pfizer-BioNtech Vaccine Variant-Resistant?
Genetic variants of SARS-CoV-2 have emerged over the course of the pandemic, threatening public health efforts to limit ...
JUN 17, 2021
Immunology
How T Cells Sense Dangerous Invaders
JUN 17, 2021
How T Cells Sense Dangerous Invaders
T cells form a major part of our immune defenses, protecting us against the constant barrage of potentially pathogenic p ...
Loading Comments...